^
BIOMARKER:

GNA11 mutation

i
Other names: G Protein Subunit Alpha 11, Guanine Nucleotide Binding Protein (G Protein) Alpha 11 (Gq Class), Guanine Nucleotide-Binding Protein G(Y) Subunit Alpha, Guanine Nucleotide-Binding Protein Subunit Alpha-11, G Alpha-11, Hypocalciuric Hypercalcemia 2, G-Protein Subunit Alpha-11, GNA-11, HYPOC2, FBH2, FHH2, HHC2, GA11, FBH
Entrez ID:
Related biomarkers:
Phase 
University of Catania
Recruiting
Last update posted :
01/05/2022
Initiation :
04/20/2021
Primary completion :
04/01/2023
Completion :
12/01/2023
GNA11
|
GNA11 mutation
Phase 2
National Cancer Institute (NCI)
Active, not recruiting
Last update posted :
07/26/2021
Initiation :
02/25/2016
Primary completion :
01/31/2022
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
|
Mekinist (trametinib)
Phase 2
National Cancer Institute (NCI)
Recruiting
Last update posted :
02/23/2021
Initiation :
04/20/2012
Primary completion :
06/30/2022
BCL2 • GNAQ • BAP1 • GNA11
|
GNAQ mutation • GNA11 mutation • BAP1 mutation
|
Zolinza (vorinostat)
Phase N/A
Institut Curie
Completed
Last update posted :
08/07/2020
Initiation :
09/01/2014
Primary completion :
02/25/2020
Completion :
02/25/2020
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
Phase 2
GlaxoSmithKline
Withdrawn
Last update posted :
12/12/2017
Initiation :
11/01/2010
Primary completion :
08/01/2011
Completion :
05/01/2012
GNAQ • GNA11
|
GNAQ mutation • GNA11 mutation
|
Mekinist (trametinib)